chr5-177592218-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017510.6(TMED9):āc.4G>Cā(p.Ala2Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000068 in 1,602,336 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_017510.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMED9 | NM_017510.6 | c.4G>C | p.Ala2Pro | missense_variant | 1/5 | ENST00000332598.7 | NP_059980.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMED9 | ENST00000332598.7 | c.4G>C | p.Ala2Pro | missense_variant | 1/5 | 1 | NM_017510.6 | ENSP00000330945.6 | ||
TMED9 | ENST00000505521.1 | n.2G>C | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152254Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000489 AC: 11AN: 224912Hom.: 0 AF XY: 0.0000324 AC XY: 4AN XY: 123396
GnomAD4 exome AF: 0.0000421 AC: 61AN: 1449970Hom.: 0 Cov.: 31 AF XY: 0.0000333 AC XY: 24AN XY: 720510
GnomAD4 genome AF: 0.000315 AC: 48AN: 152366Hom.: 0 Cov.: 33 AF XY: 0.000322 AC XY: 24AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.4G>C (p.A2P) alteration is located in exon 1 (coding exon 1) of the TMED9 gene. This alteration results from a G to C substitution at nucleotide position 4, causing the alanine (A) at amino acid position 2 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at